Maven Securities LTD Boston Scientific Corp Transaction History

Maven Securities LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $437,398 - $584,605	12,412 New	12,412 $463,000
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $1.05 Million - $1.23 Million	-27,467 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $1.13 Million - $1.26 Million	27,467 New	27,467 $1.19 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $101,966 - $116,926	-2,643 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $2.2 Million - $2.47 Million	-62,357 Reduced 95.93%	2,643 $102,000
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $2.15 Million - $2.73 Million	65,000 New	65,000 $2.34 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $2.26 Million - $2.77 Million	-65,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $1.98 Million - $2.57 Million	65,700 New	65,700 $2.31 Million

1,566

1.18B

6.78M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $146B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.